ctDNA testing offers noninvasive approach to detect minimal residual disease after surgery Skip to content The CRC Digest ctDNA testing offers noninvasive approach to detect minimal residual disease after surgery Scoping review examines how circulating tumor DNA can guide adjuvant therapy decisions and surveillance strategies in resected CRC. (Journal of Gastrointestinal Surgery) This content is informational only and does not constitute medical